187 related articles for article (PubMed ID: 14531376)
1. [Health costs, traffic--and the new editorial guidelines].
Bentsen N
Ugeskr Laeger; 2003 Aug; 165(35):3342. PubMed ID: 14531376
[No Abstract] [Full Text] [Related]
2. [Conflict of interest information--more stringent rules in the Ugeskrift].
Schroeder TV
Ugeskr Laeger; 2006 Nov; 168(46):3986. PubMed ID: 17125650
[No Abstract] [Full Text] [Related]
3. [Declaration of possible conflict of interest--is it reliable?].
Johansson M
Ugeskr Laeger; 2006 Feb; 168(9):925; author reply 925-8. PubMed ID: 16513063
[No Abstract] [Full Text] [Related]
4. [Notification of a possible conflict of interest in Ugeskrift for Laeger].
Schroeder TV
Ugeskr Laeger; 2005 Mar; 167(11):1307. PubMed ID: 15830508
[No Abstract] [Full Text] [Related]
5. [Transparency, reliability and conflict of interest].
Lunde IM; Gøtzsche PC
Ugeskr Laeger; 2011 Aug; 173(33):1989. PubMed ID: 21969951
[No Abstract] [Full Text] [Related]
6. Regarding 'Is PHARMAC's sole-supply tendering policy harming the health of New Zealanders?' editorial.
Gray B
N Z Med J; 2005 May; 118(1215):U1481; discussion U1481. PubMed ID: 15915196
[No Abstract] [Full Text] [Related]
7. [Announcement of conflict of interest in Ugeskrift for Laeger and Danish Medical Bulletin].
Rosenberg J
Ugeskr Laeger; 2011 Jan; 173(3):179. PubMed ID: 21241622
[No Abstract] [Full Text] [Related]
8. [Politization in the Ugeskrift].
Eriksen J
Ugeskr Laeger; 2008 Apr; 170(18):1574; author reply 1574. PubMed ID: 18488288
[No Abstract] [Full Text] [Related]
9. Journal of Histochemistry and Cytochemistry editorial policies and ethical guidelines.
Roth KA
J Histochem Cytochem; 2006 Feb; 54(2):129-30. PubMed ID: 16418501
[No Abstract] [Full Text] [Related]
10. [Strong tobacco].
von Eyben FE
Ugeskr Laeger; 2009 Apr; 171(15):1303; author reply 1303. PubMed ID: 19422156
[No Abstract] [Full Text] [Related]
11. [Contact to the Danish Committees on Scientific Dishonesty is the logical step].
Jensen IS
Ugeskr Laeger; 2009 Apr; 171(15):1308; author reply 1308. PubMed ID: 19422162
[No Abstract] [Full Text] [Related]
12. Letter to the editor: conflicts of interest.
Abrams P
Neurourol Urodyn; 2008; 27(4):359; discussion 359. PubMed ID: 18404619
[No Abstract] [Full Text] [Related]
13. [Titles of persons].
Lindhardt BØ; Bisgaard T
Ugeskr Laeger; 2010 Oct; 172(40):2743. PubMed ID: 20926041
[No Abstract] [Full Text] [Related]
14. PLoS Medicine and the pharmaceutical industry.
PLoS Medicine Editors
PLoS Med; 2006 Jul; 3(7):e329. PubMed ID: 17149970
[TBL] [Abstract][Full Text] [Related]
15. Regarding Pippa MacKay's editorial: the NZMA Chairman's response.
Boswell R
N Z Med J; 2005 Jun; 118(1216):U1510. PubMed ID: 15937538
[No Abstract] [Full Text] [Related]
16. [Conflict of interest: none stated].
Gulmann NC
Ugeskr Laeger; 2007 May; 169(21):2039; author reply 2039. PubMed ID: 17566238
[No Abstract] [Full Text] [Related]
17. Integrity in publishing: update on policies and statements on authorship, duplicate publications, and conflict of interest.
Yoshikawa TT; Ouslander JG
J Am Geriatr Soc; 2007 Feb; 55(2):155-7. PubMed ID: 17302649
[No Abstract] [Full Text] [Related]
18. PHARMAC welcomes debate.
Moodie P; McNee W; Metcalfe S
N Z Med J; 2005 Jul; 118(1218):U1572. PubMed ID: 16027757
[No Abstract] [Full Text] [Related]
19. Journal's policy regarding conflict of interest.
Mann R; Strom BL
Pharmacoepidemiol Drug Saf; 2003 Jun; 12(4):269-70. PubMed ID: 12812005
[No Abstract] [Full Text] [Related]
20. [No conflict of interest?].
Norum PA
Tidsskr Nor Laegeforen; 2009 Feb; 129(5):432. PubMed ID: 19247412
[No Abstract] [Full Text] [Related]
[Next] [New Search]
